These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26450572)

  • 1. A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study.
    Saad V; Wicklow B; Wittmeier K; Hay J; MacIntosh A; Venugopal N; Ryner L; Berard L; McGavock J
    BMC Pediatr; 2015 Oct; 15():151. PubMed ID: 26450572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of alanine aminotransferase elevation among normal weight, overweight and obese youth in Mexico.
    Purcell M; Flores YN; Zhang ZF; Denova-Gutiérrez E; Salmeron J
    J Dig Dis; 2013 Sep; 14(9):491-9. PubMed ID: 23678860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher waist-to-height ratio and waist circumference are predictive of metabolic syndrome and elevated serum alanine aminotransferase in adolescents and young adults in mainland China.
    Wu XY; Hu CL; Wan YH; Su PY; Xing C; Qi XY; Tao FB
    Public Health; 2012 Feb; 126(2):135-42. PubMed ID: 22177542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of ALT and the metabolic syndrome among Mexican children.
    Elizondo-Montemayor L; Ugalde-Casas PA; Lam-Franco L; Bustamante-Careaga H; Serrano-González M; Gutiérrez NG; Martínez U
    Obes Res Clin Pract; 2014; 8(1):e79-87. PubMed ID: 24548580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.
    Rehm JL; Wolfgram PM; Hernando D; Eickhoff JC; Allen DB; Reeder SB
    Eur Radiol; 2015 Oct; 25(10):2921-30. PubMed ID: 25916386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Overweight and Obesity on Liver Biochemical Markers in Children and Adolescents.
    Johansen MJ; Gade J; Stender S; Frithioff-Bøjsøe C; Lund MAV; Chabanova E; Thomsen HS; Pedersen O; Fonvig CE; Hansen T; Holm JC
    J Clin Endocrinol Metab; 2020 Feb; 105(2):. PubMed ID: 31617910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls.
    Rehm JL; Connor EL; Wolfgram PM; Eickhoff JC; Reeder SB; Allen DB
    J Pediatr; 2014 Aug; 165(2):319-325.e1. PubMed ID: 24857521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglycerides and alanine aminotransferase as screening markers for suspected fatty liver disease in obese children and adolescents.
    Oliveira AM; Oliveira N; Reis JC; Santos MV; Silva AM; Adan L
    Horm Res; 2009; 71(2):83-8. PubMed ID: 19129712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease.
    Simental-Mendía LE; Rodríguez-Hernández H; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1173-7. PubMed ID: 22735606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children.
    Koot BG; van der Baan-Slootweg OH; Bohte AE; Nederveen AJ; van Werven JR; Tamminga-Smeulders CL; Merkus MP; Schaap FG; Jansen PL; Stoker J; Benninga MA
    Obesity (Silver Spring); 2013 Mar; 21(3):583-90. PubMed ID: 23592667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver function test changes in centrally obese youth with metabolic syndrome in a Serbian population.
    Dimitrijevic-Sreckovic V; Soldatovic I; Culafic D; Sreckovic B; Popovic S; Djordjevic P; Ille T
    Metab Syndr Relat Disord; 2013 Dec; 11(6):427-33. PubMed ID: 23931675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
    Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
    Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
    Leite NC; Salles GF; Araujo AL; Villela-Nogueira CA; Cardoso CR
    Liver Int; 2009 Jan; 29(1):113-9. PubMed ID: 18384521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic steatosis and severity-related factors in obese children.
    Navarro-Jarabo JM; Ubiña-Aznar E; Tapia-Ceballos L; Ortiz-Cuevas C; Pérez-Aísa MA; Rivas-Ruiz F; Andrade RJ; Perea-Milla E
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1532-8. PubMed ID: 23701491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
    Graham RC; Burke A; Stettler N
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for liver steatosis in obese children and adolescents.
    Lin YC; Chang PF; Yeh SJ; Liu K; Chen HC
    Pediatr Neonatol; 2010 Jun; 51(3):149-54. PubMed ID: 20675238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.
    Colicchio P; Tarantino G; del Genio F; Sorrentino P; Saldalamacchia G; Finelli C; Conca P; Contaldo F; Pasanisi F
    Ann Nutr Metab; 2005; 49(5):289-95. PubMed ID: 16088092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.
    Long MT; Pedley A; Colantonio LD; Massaro JM; Hoffmann U; Muntner P; Fox CS
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1172-1180.e2. PubMed ID: 27046482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.